Experts Explain Why It's Important for Businesses to Invest 13-02-2023, 04:01

Dream Project Offers an Opportunity to win Luxury Sports 27-02-2023, 22:19

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00